Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018144570) MANAGING NEPHROGENIC DIABETES INSIPIDUS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/144570 International Application No.: PCT/US2018/016184
Publication Date: 09.08.2018 International Filing Date: 31.01.2018
IPC:
A61K 31/155 (2006.01) ,A61K 31/167 (2006.01) ,A61K 31/17 (2006.01) ,A61K 31/18 (2006.01) ,A61K 31/198 (2006.01) ,A61K 31/216 (2006.01)
[IPC code unknown for A61K 31/155][IPC code unknown for A61K 31/167][IPC code unknown for A61K 31/17][IPC code unknown for A61K 31/18][IPC code unknown for A61K 31/198][IPC code unknown for A61K 31/216]
Applicants:
EMORY UNIVERSITY [US/US]; Office of Technology Transfer 1599 Clifton Road NE, 4th Floor Atlanta, Georgia 30322, US
NEUROPN THERAPEUTICS [US/US]; 4989 Peachtree Parkway, Suite 200 Peachtree Corners, Georgia 30092, US
Inventors:
SANDS, Jeff; US
KLEIN, Janet; US
KHANNA, Ish; US
PILLARISETTI, Sivaram; US
Agent:
MASON, James C.; US
FRITTS, Laura; US
ISAACS, Randi; US
SHERER, Todd; US
Priority Data:
62/452,61631.01.2017US
Title (EN) MANAGING NEPHROGENIC DIABETES INSIPIDUS
(FR) GESTION DU DIABÈTE INSIPIDE NÉPHROGÈNE
Abstract:
(EN) In certain embodiments, this disclosure relates to methods of treating or preventing nephrogenic diabetes insipidus comprising administering an effective amount of a compound of Formula (I) or derivatives thereof, as described herein, to a subject in need thereof. In certain embodiments, the subject has been diagnosed with nephrogenic diabetes insipidus.
(FR) Dans certains modes de réalisation, la présente invention concerne des méthodes de traitement ou de prévention du diabète insipide néphrogène comprenant l'administration d'une quantité efficace d'un composé de formule (I) ou de dérivés de celui-ci, tel(s) que décrit(s) ici, à un sujet qui en a besoin. Dans certains modes de réalisation, le sujet a été diagnostiqué comme étant atteint de diabète insipide néphrogène.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)